Literature DB >> 2372988

Distribution of the MHC antigens after liver transplantation: relationship with biochemical and histological parameters.

P Rouger1, J Gugenheim, P Gane, M Capron-Landereau, F Michel, M Reynes, J Bismuth.   

Abstract

The aim of this study was to analyse the change in tissue distribution of HLA class I and class II molecules in patients during the course of liver transplantation. Sixty-one liver biopsies were analysed in 24 patients with or without rejection (acute or chronic) episode. In 93% of cases with chronic rejection and in 48% of cases with acute rejection episodes, HLA class I antigens are expressed in the membrane and/or the cytoplasm of hepatocytes. The expression of these molecules was significantly correlated with the ASP (aspartate amino transferase), AP (alkaline phosphatase), the bile duct damage and the centrolobular lesions. In contrast, the expression of HLA class II molecules is not correlated with either the type of rejection, the biological or histological findings. A strong expression of HLA class I antigen on hepatocytes after day 60 may be one of the best signs of chronic rejection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2372988      PMCID: PMC1535204          DOI: 10.1111/j.1365-2249.1990.tb03301.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  Expression of blood group antigens including HLA markers on human liver allografts.

Authors:  J Gugenheim; P Rouger; P Gane; M Capron-Laudereau; M Reynes; H Bismuth
Journal:  Transplant Proc       Date:  1987-02       Impact factor: 1.066

2.  Expression of HLA class I antigens on hepatocytes in liver disease.

Authors:  T Fukusato; M A Gerber; S N Thung; S Ferrone; F Schaffner
Journal:  Am J Pathol       Date:  1986-05       Impact factor: 4.307

3.  Expression of HLA-DR antigens on bileduct cells of rejected liver transplant.

Authors:  L Takacs; B Szende; E Monostori; A Rot; K Lapis; A Szecseny; I Ando
Journal:  Lancet       Date:  1983 Dec 24-31       Impact factor: 79.321

Review 4.  Cellular events within the rejecting allograft.

Authors:  N L Ascher; R Hoffman; D W Hanto; R L Simmons
Journal:  Transplantation       Date:  1983-03       Impact factor: 4.939

Review 5.  Evolution of liver transplantation.

Authors:  T E Starzl; S Iwatsuki; D H Van Thiel; J C Gartner; B J Zitelli; J J Malatack; R R Schade; B W Shaw; T R Hakala; J T Rosenthal; K A Porter
Journal:  Hepatology       Date:  1982 Sep-Oct       Impact factor: 17.425

6.  Induction of DR/IA antigens in human liver allografts. An immunocytochemical and clinicopathologic analysis of twenty failed grafts.

Authors:  A J Demetris; S Lasky; D H Van Thiel; T E Starzl; T Whiteside
Journal:  Transplantation       Date:  1985-11       Impact factor: 4.939

7.  Human cytotoxic T cell structures associated with expression of cytolysis. I. Analysis at the clonal cell level of the cytolysis-inhibiting effect of 7 monoclonal antibodies.

Authors:  B Malissen; N Rebai; A Liabeuf; C Mawas
Journal:  Eur J Immunol       Date:  1982-09       Impact factor: 5.532

8.  Increased expression of major histocompatibility antigens in the liver as a result of cholestasis.

Authors:  G K Innes; Y Nagafuchi; B J Fuller; K E Hobbs
Journal:  Transplantation       Date:  1988-04       Impact factor: 4.939

9.  Expression of beta-2-microglobulin on hepatocytes after liver transplantation.

Authors:  Y Nagafuchi; K E Hobbs; H C Thomas; P J Scheuer
Journal:  Lancet       Date:  1985-03-09       Impact factor: 79.321

10.  Immunohistochemical analysis of HLA (A, B, C) antigens in liver disease using a monoclonal antibody.

Authors:  C Barbatis; J Woods; J A Morton; K A Fleming; A McMichael; J O McGee
Journal:  Gut       Date:  1981-12       Impact factor: 23.059

View more
  3 in total

1.  Five-year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R.

Authors:  Sandy Feng; Anthony J Demetris; Katharine M Spain; Sai Kanaparthi; Bryna E Burrell; Udeme D Ekong; Estella M Alonso; Philip Rosenthal; Laurence A Turka; David Ikle; Nadia K Tchao
Journal:  Hepatology       Date:  2016-07-27       Impact factor: 17.425

Review 2.  Crossmatch, Donor-specific Antibody Testing, and Immunosuppression in Simultaneous Liver and Kidney Transplantation: A Review.

Authors:  Anushka Das; Timucin Taner; Jim Kim; Juliet Emamaullee
Journal:  Transplantation       Date:  2021-12-01       Impact factor: 5.385

3.  Rapid reduction of high-level pre-formed donor-specific antibodies after simultaneous liver-kidney transplantation: a report of two cases.

Authors:  Christina Lai; Allyson Newman; Jane Mawson; Frederika Abou-Daher; Narelle Watson; Avik Majumdar; Kate Wyburn; Steve Chadban; David Gracey
Journal:  BMC Nephrol       Date:  2020-02-12       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.